The apolipoprotein AII rs5082 variant is associated with reduced risk of coronary artery disease in an Australian male population

Xiao, J.Zhang, F.Wiltshire, S.Hung, J.Jennens, M.Beilby, J.Thompson, P.McQuillan, B.McCaskie, P.Carter, K.Palmer, L.Powell, B.2014-10-312014-10-312008Atherosclerosis, 2008; 199(2):333-3390021-91501879-1484http://hdl.handle.net/2440/86843Abstract not availableenCopyright © 2007 Elsevier Ireland Ltd. All rights reserved.APOAI; APOAII; Apolipoprotein; Coronary artery diseaseThe apolipoprotein AII rs5082 variant is associated with reduced risk of coronary artery disease in an Australian male populationJournal article002013666110.1016/j.atherosclerosis.2007.11.0170002587860000142-s2.0-4794909419215494Palmer, L. [0000-0002-1628-3055]